ArticleThe open AIDS journal2015
Epidemiology and management of antiretroviral-associated cardiovascular disease.
Article in The open AIDS journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- HIV and cardiovascular diseases: a systematic review and comparative risk assessment study.BMJ global health · 2026Pooled it
- Beyond viral load: Unravelling non-communicable disease patterns in Manicaland province, Zimbabwe.Journal of public health in Africa · 2025Article
- Evolving mechanisms and presentations of cardiovascular disease in people with HIV: implications for management.Clinical microbiology reviews · 2024Review
- Article
- Mild renal impairment is associated with calcified plaque parameters assessed by computed tomography angiography in people living with HIV.AIDS (London, England) · 2019Article
- The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV.Journal of the International AIDS Society · 2019Observational
- Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study.Drug design, development and therapy · 2019Observational
- Endocrinological aspects of HIV infection.Journal of endocrinological investigation · 2018Review
- Cardiovascular risk and dyslipidemia among persons living with HIV: a review.BMC infectious diseases · 2017Review
- Evidence-based review of statin use in patients with HIV on antiretroviral therapy.Journal of clinical & translational endocrinology · 2017Review
- Hyperglycemia exacerbates antiretroviral drug combination induced blood-brain barrier endothelial toxicity.Neurotoxicology · 2016Article
- What happens to cardiovascular system behind the undetectable level of HIV viremia?AIDS research and therapy · 2016Review
- Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection.The open AIDS journal · 2016Article
- Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?Current HIV/AIDS reports · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Risk and manifestations of cardiovascular disease (CVD) in patients infected with human immunodeficiency virus (HIV) will continue to evolve as improved treatments and life expectancy of these patients increases. Although initiation of antiretroviral (ARV) therapy has been shown to reduce this risk, some ARV medications may induce metabolic abnormalities, further compounding the risk of CVD. In this patient population, both pharmacologic and nonpharmacologic strategies should be employed to treat and reduce further risk of CVD. This review summarizes epidemiology data of the risk factors and development of CVD in HIV and provides recommendations to manage CVD in HIV-infected patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.